The FDA has continued to further pursue research and studies concerning the safety of all urogynecologic surgical mesh implants due to the increased number of complaints and litigations. Filed complaints continue to increase across the U.S. as the FDA looks more closely into research. Complaints began several years ago as…
A British study shows a possible link between several metal-on-metal replacement devices and an increased risk in cancer. The Sunday Telegraph, a British newspaper, disclosed results from a recent study that show the potential link. Over the past couple years, doctors and patients began second guessing the performance of metal-on-metal…
A warning letter sent by the U.S. Food and Drug Administration (FDA) puts Johnson & Johnson back in the headlines. On December 8, 2011 the FDA disclosed new information in a warning letter stating one of the company’s subsidiaries sold multiple types of orthopaedic devices with out the required approval…
Johnson & Johnson still taking a hard hit after thousands of the Depuy artificial hips were recalled in 2010. The well known company has faced hundreds of medical device lawsuits due to the failure of the product. August of 2010, the DePuy ASR XL Acetabular was recalled due to unusually…
While the Food and Drug Administration (FDA) determine whether to place a stronger emphasis on their safety warning about transvaginal mesh, a number of medical device litigations continue to spark concern. After receiving more than 1,500 complaints in just two years, the FDA is currently looking more closely into the…
As transvaginal mesh lawsuits consistently increase across the Dallas/Fort Worth area, The Food and Drug Administration (FDA) continue to warn doctors and patients of serious complications involving the surgical placement of transvaginal mesh used to repair Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). In 2008 the FDA issued…
As hip replacement lawsuits continue to rise, so do serious health concerns about metal-on-metal hip replacements. According to the New York Times, a top Boston surgeon went in to replace his 53-year-old patient’s hip and found devastating results. What researchers had warned patients of years ago has finally sunk in.…
Is DePuy Orthopaedics facing yet another possible recall due to a defective medical device? August of 2010, the DePuy ASR XL Acetabular was recalled due to unusually high rates of hip implant failure within only a few years of surgery. DePuy estimated the failure rate to be about 12-13 percent…